DaVita to Present at UBS Global Healthcare Conference

DENVER, Nov. 8, 2024 — DaVita Inc. (NYSE: DVA) announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST).

To view the live webcast, visit the UBS page and create a free registration.

About DaVita Inc.

DaVita (NYSE: DVA) is a health care provider committed to transforming care delivery and improving quality of life for patients around the world. As a leading comprehensive kidney care provider, DaVita has been at the forefront of clinical quality and innovation for over two decades. DaVita provides care to patients at every stage and setting of their kidney health journey, from slowing the progression of kidney disease to supporting transplantation, and from acute hospital care to dialysis at home. As of September 30, 2024, DaVita served approximately 265,400 patients at 3,113 outpatient dialysis centers, with 2,660 centers in the United States and 453 centers in 13 other countries. DaVita has achieved reductions in hospitalizations, improvements in mortality rates, and worked collaboratively to drive the kidney care industry toward equitable and high-quality care for all patients, regardless of location. For more information, visit .

Contact Information

DaVita Logo (PRNewsfoto/DaVita)

 

SOURCE DaVita

elong